[Event Information]
GSDM 18th Platform Seminar
“University of Tokyo-Brookings Health Symposium for Accountable Care and Biomedical Innovation”
7th July, 2014 9:00-15:30
8th July, 2014 8:30-12:30
(Fukutake Learning Theater , B2 Fukutake Hall, the University of Tokyo Hongo Campus）
2014/06/24
| Date | : | July 7 9：00～15：30 （Open：8：30） July 8 8：30～12：30 （Open：8：00） |
|---|---|---|
| Venue | : | Fukutake Learning Theater , B2 Fukutake Hall, the University of Tokyo Hongo Campus |
| Hosted by | : |
Graduate School of Public Policy, the University of Tokyo Global Leader Program for Social Design and Management(GSDM), the University of Tokyo UTokyo Policy Alternatives Research Institute(PARI), the University of Tokyo Policy Thinknet |
| Supported by | : | Meiji Institute for Global Affairs National Institute of Population and Social Security Research The Murata Science Foundation Research Fund |
*Admission : Free
*English/Japanese (with simultaneous interpretation in Japanese and English)
*Panelists are subject to change.
Day 1 (1): Payment and Delivery Reforms for Accountable Care
| 9:00 a.m. | Opening Remarks Yoichiro Matsumoto, Vice President Dean, University of Tokyo Mark McClellan, Initiative on Innovation and Value for Healthcare, Economic Studies, The Brookings Institution |
|---|---|
| 9:15 a.m. | Keynote: Innovative Payment and Delivery Reforms for Accountable Care Mark McClellan Objective: To provide an overview of ongoing reforms in the US that are shifting payment away from fee-for-service and toward person-centered payment and delivery. Furthermore, this keynote will introduce the conceptual framework for accountable care and begin to link how accountable care can be paired with universal health care in Japan. |
| 9:45 a.m. | Panel Discussion: Addressing Key Challenges to Implementing Payment Reform Models in Japan Objective: To identify and describe opportunities for better care in Japan. Panelists will talk about current reform activities taking place in Japan and describe key challenges to implementing reforms. This discussion will lay the foundation for the subsequent Plenary Discussion on accountable care.
|
| 10:45 a.m. | Break |
| 11:00 p.m. | Using Health IT to Support Health Care Reform and Improve Care Objective: To elaborate on how health IT innovation in Japan can promote real-time, transparent data exchange. Panelists will discuss current health IT developments in Japan and how they align with the health payment system. Panel Discussion:
|
| 12:00 p.m. | Lunch |
| 12:45 p.m. | Plenary Discussion: Identifying a Path to Accelerate Accountable Care in JapanObjective: To develop potential solutions to strengthen accountability and transition the Japanese system toward a more accountable model of care. We propose to work with Japanese experts to write a white paper that describes the current state of the Japanese health system using an accountable care conceptual framework. Discussants will be given the draft paper on the Japanese experience with accountable care to read prior to the conference. After a short overview of the WISH conceptual framework and accountable care, discussants will discuss the current state of the Japanese health system using the accountable care conceptual framework. Attendees will work in smaller groups, focusing on one conceptual pillar of the accountable care framework, to develop potential solutions to strengthen accountability in the Japanese health system.Lead Author Presentation:Mark McClellan and Chiaki Sato |
Day 1 (2): Reform with Bio-Medical Innovation
| 2:00 p.m | Keynote: Strengthening the Biomedical Innovation Ecosystem Gregory Daniel, Engelberg Center for Health Care Reform, The Brookings Institution In order to improve the biomedical innovation process, it is important to understand the challenges innovators are facing and to better define how successful innovation will be measured. This keynote will focus on the overarching systemic issues in medical product development, the key factors driving it, and potential metrics for assessing progress in the treatment of disease. |
|---|---|
| 2: 15 p.m. | Panel Discussion: Expediting Clinical Development and Regulatory Review of Novel Medical Products Moderator: Gregory Daniel From pre-competitive consortia to targeted venture philanthropy, adaptive clinical trials to new FDA approval pathways, many emerging efforts to improve the creation of drugs and devices are underway in the United States. This panel will highlight the collaborative progress being made in basic, translational, clinical, and regulatory sciences, with a particular emphasis on the role of governmental agencies and public policy.Panel Discussion:
|
| 3:00 p.m. | Q&A |
| 3:30 p.m. | Closing Remarks and Adjournment Mark McClellan |
Day 2: Payment Reform with Bio-Medical Innovation
| 8:30 a.m. | Opening Remarks Mark McClellan, Initiative on Innovation and Value for Healthcare, Economic Studies, The Brookings InstitutionHideaki Shiroyama, Dean for Graduate School of Public Policy, The University of Tokyo |
|---|---|
| 8:45 a.m. | Panel Discussion: Post-market Evidence Generation and the Learning Health Care SystemModerator: Gregory DanielThe post-market environment, which begins with the regulatory approval of a product and extends throughout its clinical use, is becoming an increasingly fertile ground for research and study. Emerging safety surveillance networks such as FDA’s Sentinel Initiative are being established to track the safety of drugs and devices. Registries that collect data on patient outcomes are becoming a more routine part of care. Comparative effectiveness research holds the promise of giving patients, providers, and payers better information on what treatments work. This panel will review recent developments in these areas and discuss how they can contribute to a truly learning health care system. Hiroshi Yamamoto, Chief Safety Officer, Pharmaceuticals and Medical Devices Agency Ichiro Sakuma, Ph. D., Professor, Graduate School of Engineering, the University of Tokyo/Deputy Center Director (for Medical Devices), Pharmaceuticals and Medical Devices Agency, Japan Takashi Shimada, Vice President, Medtronic, Inc. and President, Medtronic Japan Co., Ltd Hiromichi Shirasawa, M.D., Vice President and Executive Officer, Head of Japan Development, MSD K.K. Haruko Yamamoto, Director of the Division of Advanced Medicine and Promoting Clinical Trials, the National Cerebral and Cardiovascular Center |
| 9:45 a.m. | Q&A |
| 10: 30 a.m. | Break |
| 10:45 a.m. | Plenary Discussion: Identifying Ways to Advance Payment Reform and Bio-Medical Innovations in Japan Objective: To facilitate discussion on strategies to integrate accountable care and biomedical advances into current Japanese health reforms. Discussants:
|
| 12:15 p.m. | Closing Remarks Mark McClellan Ryozo Hayashi, LL.M., Director, Meiji Institute For Global Affairs |
| 12:30 p.m. | Adjourn |